Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

975 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Design, synthesis and biological evaluation of novel pyrazolo-pyrimidin-amines as potent and selective BTK inhibitors.
Joshi D, Bahekar R, Soman S, Jadav P, Patel D, Goswami A, Pethani J, Kumar J, Patel J, Sundar R, Goswami P, Goshdastidar K, Patel H, Patel A, Bandyopadhyay D, Chattarjee A, Sharma M, Jain M, Desai R. Joshi D, et al. Among authors: bandyopadhyay d. Bioorg Chem. 2023 Jan;130:106238. doi: 10.1016/j.bioorg.2022.106238. Epub 2022 Nov 14. Bioorg Chem. 2023. PMID: 36403335
Discovery of 1,3-dihydro-2H-imidazo[4,5-c]quinolin-2-ones based novel, potent and PI3Kδ selective inhibitors.
Bahekar R, Dave B, Soman S, Patel D, Chopade R, Funde R, Kumar J, Sachchidanand S, Giri P, Chatterjee A, Mahapatra J, Vyas P, Ghoshdastidar K, Bandyopadhyay D, Desai RC. Bahekar R, et al. Among authors: bandyopadhyay d. Bioorg Med Chem Lett. 2019 Jun 1;29(11):1313-1319. doi: 10.1016/j.bmcl.2019.04.007. Epub 2019 Apr 4. Bioorg Med Chem Lett. 2019. PMID: 30975623
Discovery of diaminopyrimidine-carboxamide derivatives as JAK3 inhibitors.
Bahekar R, Panchal N, Soman S, Desai J, Patel D, Argade A, Gite A, Gite S, Patel B, Kumar J, S S, Patel H, Sundar R, Chatterjee A, Mahapatra J, Patel H, Ghoshdastidar K, Bandyopadhyay D, Desai RC. Bahekar R, et al. Among authors: bandyopadhyay d. Bioorg Chem. 2020 Jun;99:103851. doi: 10.1016/j.bioorg.2020.103851. Epub 2020 Apr 18. Bioorg Chem. 2020. PMID: 32334196
ZYBT1, a potent, irreversible Bruton's Tyrosine Kinase (BTK) inhibitor that inhibits the C481S BTK with profound efficacy against arthritis and cancer.
Ghoshdastidar K, Patel H, Bhayani H, Patel A, Thakkar K, Patel D, Sharma M, Singh J, Mohapatra J, Chatterjee A, Patel D, Bahekar R, Sharma R, Gupta L, Patel N, Giri P, Srinivas NR, Jain M, Bandyopadhyay D, Patel PR, Desai RC. Ghoshdastidar K, et al. Among authors: bandyopadhyay d. Pharmacol Res Perspect. 2020 Aug;8(4):e00565. doi: 10.1002/prp2.565. Pharmacol Res Perspect. 2020. PMID: 32790160 Free PMC article.
Optimisation of momelotinib with improved potency and efficacy as pan-JAK inhibitor.
Desai J, Patel B, Gite A, Panchal N, Gite S, Argade A, Kumar J, Sachchidanand S, Bandyopadhyay D, Ghoshdastidar K, Patel H, Chatterjee A, Mahapatra J, Sharma M, Giri P, Kumar S, Jain M, Sharma R, Desai R. Desai J, et al. Among authors: bandyopadhyay d. Bioorg Med Chem Lett. 2022 Jun 15;66:128728. doi: 10.1016/j.bmcl.2022.128728. Epub 2022 Apr 9. Bioorg Med Chem Lett. 2022. PMID: 35413417
Discovery of orally active, potent, and selective benzotriazole-based PTP1B inhibitors.
Patel D, Jain M, Shah SR, Bahekar R, Jadav P, Darji B, Siriki Y, Bandyopadhyay D, Joharapurkar A, Kshirsagar S, Patel H, Shaikh M, Sairam KV, Patel P. Patel D, et al. Among authors: bandyopadhyay d. ChemMedChem. 2011 Jun 6;6(6):1011-6. doi: 10.1002/cmdc.201100077. Epub 2011 Apr 19. ChemMedChem. 2011. PMID: 21506278 No abstract available.
Identification of a novel orally bioavailable NLRP3 inflammasome inhibitor.
Agarwal S, Pethani JP, Shah HA, Vyas V, Sasane S, Bhavsar H, Bandyopadhyay D, Giri P, Viswanathan K, Jain MR, Sharma R. Agarwal S, et al. Among authors: bandyopadhyay d. Bioorg Med Chem Lett. 2020 Nov 1;30(21):127571. doi: 10.1016/j.bmcl.2020.127571. Epub 2020 Sep 24. Bioorg Med Chem Lett. 2020. PMID: 32980515 Free PMC article.
Discovery of novel, potent and orally efficacious inhibitor of neutral amino acid transporter B0AT1 (SLC6A19).
Desai J, Patel B, Darji B, Gite A, Panchal N, Bhosale G, Shedage S, Patel S, Kadam P, Patel G, Kumar Srivastava B, Joharapurkar A, Kshirsagar S, Giri P, Bhayani H, Patel A, Ghoshdastidar K, Bandyopadhyay D, Kumar S, Jain M, Sharma R. Desai J, et al. Among authors: bandyopadhyay d. Bioorg Med Chem Lett. 2021 Dec 1;53:128421. doi: 10.1016/j.bmcl.2021.128421. Epub 2021 Oct 27. Bioorg Med Chem Lett. 2021. PMID: 34718128
975 results